Evofem CEO Demands Overhaul of Women’s Health at Fierce JPM Week 2026

Reuters
01/26
Evofem CEO Demands Overhaul of Women’s Health at Fierce <a href="https://laohu8.com/S/JPM">JPM</a> Week 2026

Evofem Biosciences Inc. CEO Saundra Pelletier delivered a powerful keynote address at Fierce JPM Week 2026, calling for a fundamental reset in women’s health. Pelletier highlighted the historical neglect of women’s health issues, stating, “If men suffered from endometriosis, it would be solved by now,” and criticized the exclusion of women from clinical trials due to perceptions about hormonal complexity. She emphasized Evofem’s commitment to prioritizing transparency, education, and respect in their approach to women’s health. The full keynote, titled “Rebuilding Women’s Health from the Ground Up,” is available for on-demand viewing via Fierce Pharma. Register for Fierce JPM Week 2026 and scroll to "Friday, January 23" to access the session.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evofem Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260123678836) on January 23, 2026, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10